Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Concentrations: Measurements01:23

Drug Concentrations: Measurements

Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elimination of porcine reproductive and respiratory syndrome from the United States: what is the road map to success?

Journal of the American Veterinary Medical Association·2026
Same author

The first 5 years of Bioanalysis: a story of growth and evolution.

Bioanalysis·2013
Same author

Increasing productivity in regulated bioanalytical laboratories: maximizing the use of resources.

Bioanalysis·2013
Same author

Conference report: Discussion on harmonization and globalization of bioanalytical guidances at the 19th International Reid Bioanalytical Forum.

Bioanalysis·2011
Same author

Bioanalysis in drug discovery.

Bioanalysis·2011
Same author

2011 Bioanalysis Young Investigator Award.

Bioanalysis·2011
Same journal

A simple, sensitive microsample LC-MS assay for quercetin and isorhamnetin in mouse and human plasma: application to EMIQ treatment in myotonic dystrophy type 1.

Bioanalysis·2026
Same journal

ADA assays for high-dose biologics: redefining drug tolerance through clinical insights.

Bioanalysis·2026
Same journal

Comparison of SERS spectral data sets of blood serum samples of hypopharyngeal cancer using silver and gold nanoparticles as substrates.

Bioanalysis·2026
Same journal

The Gyrolab platform for immunogenicity assessment and biotherapeutic and biomarker analysis: technical advances and bioanalytical applications.

Bioanalysis·2026
Same journal

Simultaneous quantification of D-penicillamine, D-penicillamine disulfide, and L-cysteine-D-penicillamine disulfide in human plasma: optimization of sample preparation and mass spectrometry procedures to support bioequivalence studies.

Bioanalysis·2026
Same journal

Development and preliminary clinical application of a time-resolved fluoroimmunoassay for anti-rituximab antibodies in membranous nephropathy.

Bioanalysis·2026
See all related articles

Related Experiment Video

Updated: May 26, 2026

A BW Reporter System for Studying Receptor-Ligand Interactions
06:05

A BW Reporter System for Studying Receptor-Ligand Interactions

Published on: January 7, 2019

Conference report: the 19th International Reid Bioanalytical Forum.

Howard Hill1

  • 1Huntingdon Life Sciences, Woolley Road, Alconbury, Huntingdon, Cambridgeshire, UK. hillh@ukorg.huntingdon.com

Bioanalysis
|December 22, 2011
PubMed
Summary
This summary is machine-generated.

The 19th International Reid Bioanalytical Forum highlighted advancements in bioanalysis, focusing on safety testing metabolites, regulatory issues, and novel LC-MS technologies for protein and peptide quantitation. Emerging trends in dried blood spot analysis were also a key discussion point.

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Related Experiment Videos

Last Updated: May 26, 2026

A BW Reporter System for Studying Receptor-Ligand Interactions
06:05

A BW Reporter System for Studying Receptor-Ligand Interactions

Published on: January 7, 2019

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Area of Science:

  • Bioanalytical Chemistry
  • Analytical Chemistry
  • Biomarker Discovery

Background:

  • The 19th International Reid Bioanalytical Forum convened over 120 participants to discuss key developments in bioanalysis.
  • The forum addressed diverse topics crucial for drug development and safety assessment.

Framework:

  • Sessions covered metabolites in safety testing, emphasizing enabling technologies and philosophies.
  • Regulatory-based issues were presented, initiated by experts from the US FDA.

Implementation:

  • Discussions included developing technologies and troubleshooting in Liquid Chromatography-Mass Spectrometry (LC-MS).
  • Experiences in bioanalysis within the drug discovery environment were shared.
  • The rapidly advancing field of protein and peptide quantitation using LC-MS was explored.

Implications:

  • Biomarker-based topics were integrated throughout the forum.
  • The meeting concluded with a highly attended session on trends in dried blood spot analysis.
  • These discussions provide insights into current practices and future directions in bioanalytical science.